Keywords: voyager-durect, alzheimer, therapy, enters, phase, voyager, pharmaceutical

Voyager-Durect Alzheimer therapy enters Phase I

Article | 14 February 2005

Print This

Voyager Pharmaceutical Corp of the USA and drug-delivery technology firm Durect have announced completion of enrollment for trials of their ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in